Eclectus Pharmaceuticals Private Limited - Company Profile

It is a non-profit organizations private limited company based in Allahabad, Uttar Pradesh, India, established in 2019.
2019 Allahabad, Uttar Pradesh, India Active
Last Updated:
About Eclectus Pharmaceuticals Private Limited

Eclectus Pharmaceuticals Private Limited, a active private limited company, was established on 28 March 2019 in Allahabad, Uttar Pradesh, India. Engaging in social work within the non-profit organizations sector, it holds CIN: U85320UP2019PTC115189. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ajeet Singh (Additional Director), Shweta Shukla (Director). Past directors included Jay Kant Shukla. It is based at Chakrana Tiwari Govind Puram Naini, Allahabad, Uttar Pradesh, 211008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85320UP2019PTC115189

  • Registration Number

    115189

  • Incorporation Date

    28 March 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 10 Months
Company report

Eclectus Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Eclectus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Eclectus Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ajeet Singh Additional Director 12 Nov 2019 Current
Shweta Shukla Director 28 Mar 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Jun 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eclectus Pharmaceuticals.

Enhance accessibility to Eclectus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Eclectus Pharmaceuticals revenue growth over time
Eclectus Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eclectus Pharmaceuticals?

Unlock access to Eclectus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Eclectus Pharmaceuticals?

Unlock and access historical data on people associated with Eclectus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eclectus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eclectus Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eclectus Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Ajeet Singh was appointed as a Additional Director was appointed as a Additional Director on 12 Nov 2019 & has been associated with this company since 6 years 3 months . was documented.

  • Director Appointment

    Shweta Shukla was appointed as a Director was appointed as a Director on 28 Mar 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.

  • Company Incorporation

    Eclectus Pharmaceuticals Private Limited was registered on 28 Mar 2019 with Roc Kanpur & aged 6 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Eclectus Pharmaceuticals Private Limited?

The CIN of Eclectus Pharmaceuticals Private Limited is U85320UP2019PTC115189.

Where is Eclectus Pharmaceuticals Private Limited headquartered?

Eclectus Pharmaceuticals Private Limited is headquartered at Chakrana Tiwari Govind Puram Naini, Allahabad, Uttar Pradesh, 211008.

When was Eclectus Pharmaceuticals Private Limited incorporated?

Eclectus Pharmaceuticals Private Limited was incorporated on 28 March 2019.

Who are the current directors of Eclectus Pharmaceuticals Private Limited?

The current directors of Eclectus Pharmaceuticals Private Limited are

What is the primary industry of Eclectus Pharmaceuticals Private Limited?

The primary industry of Eclectus Pharmaceuticals Private Limited is Non-Profit Organizations.

Is Eclectus Pharmaceuticals Private Limited a listed company?

Eclectus Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Eclectus Pharmaceuticals Private Limited?

The authorized capital of Eclectus Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available